These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 29473326)
1. Prediction of radiotherapy response with a 5-microRNA signature-based nomogram in head and neck squamous cell carcinoma. Chen L; Wen Y; Zhang J; Sun W; Lui VWY; Wei Y; Chen F; Wen W Cancer Med; 2018 Mar; 7(3):726-735. PubMed ID: 29473326 [TBL] [Abstract][Full Text] [Related]
2. Construction of an 11-microRNA-based signature and a prognostic nomogram to predict the overall survival of head and neck squamous cell carcinoma patients. Huang Y; Liu Z; Zhong L; Wen Y; Ye Q; Cao D; Li P; Liu Y BMC Genomics; 2020 Oct; 21(1):691. PubMed ID: 33023466 [TBL] [Abstract][Full Text] [Related]
3. A robust six-miRNA prognostic signature for head and neck squamous cell carcinoma. Zhao X; Cui L J Cell Physiol; 2020 Nov; 235(11):8799-8811. PubMed ID: 32342519 [TBL] [Abstract][Full Text] [Related]
4. Identification of an individualized therapy prognostic signature for head and neck squamous cell carcinoma. Lin C; Chen Y; Pan J; Lu Q; Ji P; Lin S; Liu C; Lin S; Li M; Zong J BMC Genomics; 2023 Apr; 24(1):221. PubMed ID: 37106442 [TBL] [Abstract][Full Text] [Related]
5. Six-MicroRNA Prognostic Signature in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma. Worakitchanon W; Panvongsa W; Siripoon T; Kitdumrongthum S; Wongpan A; Arsa L; Trachu N; Jinawath N; Chairoungdua A; Ngamphaiboon N JCO Precis Oncol; 2023 May; 7():e2300003. PubMed ID: 37163716 [TBL] [Abstract][Full Text] [Related]
6. Identification of a nomogram based on an 8-lncRNA signature as a novel diagnostic biomarker for head and neck squamous cell carcinoma. Mao R; Chen Y; Xiong L; Liu Y; Zhang T Aging (Albany NY); 2020 Oct; 12(20):20778-20800. PubMed ID: 33091878 [TBL] [Abstract][Full Text] [Related]
7. Expression level and prospective mechanism of miRNA-99a-3p in head and neck squamous cell carcinoma based on miRNA-chip and miRNA-sequencing data in 1, 167 cases. Wei GG; Guo WP; Tang ZY; Li SH; Wu HY; Zhang LC Pathol Res Pract; 2019 May; 215(5):963-976. PubMed ID: 30904360 [TBL] [Abstract][Full Text] [Related]
8. A novel seven‑miRNA prognostic model to predict overall survival in head and neck squamous cell carcinoma patients. Lu L; Wu Y; Feng M; Xue X; Fan Y Mol Med Rep; 2019 Nov; 20(5):4340-4348. PubMed ID: 31545440 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-15b-5p Predicts Locoregional Relapse in Head and Neck Carcinoma Patients Treated With Intensity-modulated Radiotherapy. Ahmad P; Sana J; Slavik M; Gurin D; Radova L; Gablo NA; Kazda T; Smilek P; Horakova Z; Gal B; Hermanova M; Slampa P; Slaby O Cancer Genomics Proteomics; 2019; 16(2):139-146. PubMed ID: 30850365 [TBL] [Abstract][Full Text] [Related]
10. Deep sequencing-based microRNA expression signatures in head and neck squamous cell carcinoma: dual strands of pre-miR-150 as antitumor miRNAs. Koshizuka K; Nohata N; Hanazawa T; Kikkawa N; Arai T; Okato A; Fukumoto I; Katada K; Okamoto Y; Seki N Oncotarget; 2017 May; 8(18):30288-30304. PubMed ID: 28415821 [TBL] [Abstract][Full Text] [Related]
11. Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma. Koshizuka K; Hanazawa T; Kikkawa N; Katada K; Okato A; Arai T; Idichi T; Osako Y; Okamoto Y; Seki N Auris Nasus Larynx; 2018 Aug; 45(4):854-865. PubMed ID: 29233721 [TBL] [Abstract][Full Text] [Related]
12. Histopathological image and gene expression pattern analysis for predicting molecular features and prognosis of head and neck squamous cell carcinoma. Chen L; Zeng H; Zhang M; Luo Y; Ma X Cancer Med; 2021 Jul; 10(13):4615-4628. PubMed ID: 33987946 [TBL] [Abstract][Full Text] [Related]
13. Autophagy-Related Signature for Head and Neck Squamous Cell Carcinoma. Li C; Wu ZH; Yuan K Dis Markers; 2020; 2020():8899337. PubMed ID: 33133307 [TBL] [Abstract][Full Text] [Related]
14. A prognostic mRNA expression signature of four 16q24.3 genes in radio(chemo)therapy-treated head and neck squamous cell carcinoma (HNSCC). Wintergerst L; Selmansberger M; Maihoefer C; Schüttrumpf L; Walch A; Wilke C; Pitea A; Woischke C; Baumeister P; Kirchner T; Belka C; Ganswindt U; Zitzelsberger H; Unger K; Hess J Mol Oncol; 2018 Dec; 12(12):2085-2101. PubMed ID: 30259648 [TBL] [Abstract][Full Text] [Related]
15. Immune-related miRNA signature identifies prognosis and immune landscape in head and neck squamous cell carcinomas. Ma B; Li H; Qiao J; Meng T; Yu R Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33111959 [TBL] [Abstract][Full Text] [Related]
16. Nomogram Based on microRNA Signature Contributes to Improve Survival Prediction of Clear Cell Renal Cell Carcinoma. Zhao E; Bai X Biomed Res Int; 2020; 2020():7434737. PubMed ID: 32280701 [TBL] [Abstract][Full Text] [Related]
17. A novel comprehensive immune-related gene signature as a promising survival predictor for the patients with head and neck squamous cell carcinoma. Fang R; Iqbal M; Chen L; Liao J; Luo J; Wei F; Wen W; Sun W Aging (Albany NY); 2021 Apr; 13(8):11507-11527. PubMed ID: 33867351 [TBL] [Abstract][Full Text] [Related]
19. Combined identification of three miRNAs in serum as effective diagnostic biomarkers for HNSCC. Liu C; Yu Z; Huang S; Zhao Q; Sun Z; Fletcher C; Jiang Y; Zhang D EBioMedicine; 2019 Dec; 50():135-143. PubMed ID: 31780396 [TBL] [Abstract][Full Text] [Related]
20. A nomogram based on a gene signature for predicting the prognosis of patients with head and neck squamous cell carcinoma. Yang B; Fu L; Xu S; Xiao J; Li Z; Liu Y Int J Biol Markers; 2019 Sep; 34(3):309-317. PubMed ID: 31452437 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]